Logo-jpe
Submitted: 05 Apr 2020
Accepted: 14 Nov 2020
ePublished: 29 Dec 2020
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Prev Epidemiol. 2020;5(2): e25.
doi: 10.34172/jpe.2020.25
  Abstract View: 110
  PDF Download: 46

Original

The changes in therapeutic and managerial protocols for patients suffering ST-segment elevation myocardial infarction in COVID-19 pandemic: A systematic review and meta-analysis

Hosna Mirfakhraee ORCID logo, maryam niksolat * ORCID logo, Samaneh Saghafian larijani * ORCID logo, zhale zandie

Abstract

introduction:Apart from the direct effect of COVID-19 disease on the incidence of ischemic heart disease, the pandemic effect of this infection on the control of ischemic heart disease, on the clinical consequences of these patients and their hospital admission is also significant.objective: The present review attempted to assess the admission rate, treatment protocols, and outcome changes in patients suffering STEMI in the COVID-19 outbreak. Patient and Methods: The included studies were identified through electronically reviewing the manuscripts databases of MEDLINE, EMBASE,Web of knowledge,and Google Scholar from inception to September 2020. the titles and abstracts of the manuscripts were screened by Two blinded reviewers. followed by an in-depth assessment of the full texts for assigning the inclusion appropriateness.Results: Eighteen articles (including 6225 STEMI patients hospitalized within the COVID-19 pandemic duration and 55711STEMI patients in pre-COVID-19 periods) were desirable for the final analysis. A longer delay among symptom onset and first medical contact in the COVID-19 lockdown period than before the COVID-19 pandemic was revealed.Comparing STEMI-related death in the COVID-19 period compared to the pre-COVID-19 duration showed a significantly higher death rate and a higher rate of thrombolytic therapy.The examined pre-COVID-19 and COVID-19 periods showed a reduction in STEMI patients’ admissions reached 30.9%.entering the COVID-19 period resulted in a significant 44.4% reduction in the number of primary percutaneous coronary intervention.Conclusion: During the COVID-19 pandemic, the management of STEMI has undergone significant changes,including reduced hospital admissions,reduced invasive and semi-invasive treatment interventions,increased STEMI-related mortality, increased thrombolytic therapy, and delayed patients’ referral to the hospitals
Keywords: myocardial infarction, Covid-19, ST-segment
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 110

Your browser does not support the canvas element.


PDF Download: 46

Your browser does not support the canvas element.